Thermo Fisher Scientific Stock News

​​​​​Thermo Fisher Scientific Inc (NYSE: TMO) said that its COVID-19 diagnostic tests can accurately detect the new coronavirus variant Omicron. The Omicron variant has more than 30 mutatio

Ritholtz Wealth Management grew its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 10.4% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,538 shares of the medical research companys stock after buying an additional 334 shares during the period. Ritholtz Wealth Managements holdings []

Unigestion Holding SA trimmed its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 77.7% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 483 shares of the medical research companys stock after selling 1,687 shares during the quarter. Unigestion Holding SAs holdings in Thermo Fisher Scientific were worth $280,000 as of its []

Overview Drugs affect individuals in various ways. For example, one drug may cause an increased heart rate, slightly faster breathing and an increase in blood pressure while another may cause drowsiness, lack of focus and memory loss. These differences in the

Overview: Cell lysis is a key step for research or study in proteomics as the extraction of protein depends on the cell lysis. It is an important step that is needed to perform nuclear extraction, after which using recombinant DNA technology

Dublin, Nov. 26, 2021 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Manufacturing Market, By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumour Cell Therapies, Stem Cell Therapies), By Source of Cell, By Scale of Operation, By Source, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com''s offering.

Scaffold Technology market report performs thorough analysis of the potential of the market in the present and the future prospects from various angles. The report provides segmentation of the global market on the basis of technology, application, product, and region.

NEW YORK , Nov. 25, 2021 /PRNewswire/ -- Technavio''s latest offering Induced Pluripotent Stem Cells Production Market report provides a detailed analysis on the competitive scenario and the market growth across various regions. The induced pluripotent stem cells production market value is expected to grow by USD 1.55 billion , progressing at a CAGR of 11.39% from 2021 to 2026. 33% of the market''s growth will originate from North America . The US is a key market for induced pluripotent stem cells production in North America. For more insights on Induced Pluripotent Stems Cells Production Market - Download a free sample now! Market Dynamics The market is driven by factors such as the technological advancements in manufacturing, the rising prevalence of several chronic disorders such as diabetes, heart disease, stroke, and cancer, and the rising financial assistance by governments . However, the lack of awareness is hindering market growth. Company Profiles The induced pluripotent stem cells production market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.

Analysts expect Thermo Fisher Scientific Inc. (NYSE:TMO) to report $4.82 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Five analysts have issued estimates for Thermo Fisher Scientifics earnings, with the highest EPS estimate coming in at $4.87 and the lowest estimate coming in at $4.78. Thermo Fisher Scientific posted earnings of []

Growing cases infectious diseases and cancer is expected to boost the global 3D cell culture market growth over the forecast period. Moreover, increasing demand for 3D cell culture for treatment of numerous diseases is expected to accelerate the market growth

Overview: Recombinant DNA technology involves joining of two DNA molecules from two different species. It allows transfer of preferred specific characteristics, which helps to improve pre-existing systems and controls expression of target genes. Mass production of therapeutic proteins characterized by higher

Northwest Bancshares Inc. purchased a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO) in the 3rd quarter, HoldingsChannel reports. The firm purchased 377 shares of the medical research company’s stock, valued at approximately $215,000. A number of other institutional investors also recently made changes to their positions in the business. MV Capital Management Inc. lifted […]

Global Solid Phase Extraction Market Overview: To accomplish highest return on investment (ROI), it’s very essential to know about market parameters such as brand awareness, market landscape, possible future issues, industry trends and customer behaviour where Solid Phase Extraction Market report

The "Vitro Diagnostics Reagents" Market report offers qualitative and quantitative insights and a detailed analysis of market size & growth rate for all possible segments in the market. The Global Vitro Diagnostics Reagents Industry presents a market overview, product details,

Avenue 1 Advisors LLC lowered its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 5.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 435 shares of the medical research companys stock after selling 26 shares during the quarter. []